Quotient Sciences specializes in accelerating drug development through a fully integrated approach that encompasses various stages of the process, from drug product development and manufacturing to clinical pharmacology studies. Their unique offering, known as Translational Pharmaceutics®, combines real-time cGMP manufacturing with clinical activities, allowing for rapid adaptation and optimization of drug formulations. This integration is designed to streamline the transition from initial candidate selection to first-in-human clinical testing and ultimately to commercial supply, ensuring that new therapies reach patients quickly and efficiently.

The company also emphasizes its capabilities in pediatric and orphan drug development, providing tailored solutions that address the specific needs of these populations. Quotient Sciences employs advanced techniques for formulating age-appropriate dosage forms, including taste-modifying strategies to enhance palatability without compromising stability or pharmacokinetic performance. Their extensive experience in clinical pharmacology, supported by state-of-the-art facilities in the U.S. and U.K., enables them to conduct a wide range of studies, including first-in-human trials and drug-drug interaction assessments, ensuring high-quality data and insights that facilitate informed decision-making throughout the drug development journey.

United Kingdom

Provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry.

Quotient Sciences

Company Details